The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility
We applied a targeted sequencing approach to identify germline mutations conferring a moderately to highly increased risk of cutaneous and uveal melanoma. Ninety‐two high‐risk melanoma patients were screened for inherited variation in 120 melanoma candidate genes. Observed gene variants were filtere...
Saved in:
Published in | Genes chromosomes & cancer Vol. 55; no. 7; pp. 601 - 611 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.07.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We applied a targeted sequencing approach to identify germline mutations conferring a moderately to highly increased risk of cutaneous and uveal melanoma. Ninety‐two high‐risk melanoma patients were screened for inherited variation in 120 melanoma candidate genes. Observed gene variants were filtered based on frequency in reference populations, cosegregation with melanoma in families and predicted functional effect. Several novel or rare genetic variants in genes involved in DNA damage response, cell‐cycle regulation and transcriptional control were identified in melanoma patients. Among identified genetic alterations was an extremely rare variant (minor allele frequency of 0.00008) in the BRIP1 gene that was found to cosegregate with the melanoma phenotype. We also found a rare nonsense variant in the BRCA2 gene (rs11571833), previously associated with cancer susceptibility but not with melanoma, which showed weak association with melanoma susceptibility in the Swedish population. Our results add to the growing knowledge about genetic factors associated with melanoma susceptibility and also emphasize the role of DNA damage response as an important factor in melanoma etiology. © 2016 Wiley Periodicals, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-63245SQX-Z ArticleID:GCC22363 istex:2940CB0ABCF0A7026728DA1239A612E8C0D1D602 Supported by: The Swedish Research Council (NT); the Swedish Cancer Society; Karolinska Institutet's Foundation Grants for Eye Research and Carmen and Bertil Regnérs Foundation; Knut and Alice Wallenberg Foundation to the Wallenberg Advanced Bioinformatics Infrastructure ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1045-2257 1098-2264 1098-2264 |
DOI: | 10.1002/gcc.22363 |